| Fair shares and sharing fairly: a survey of public views on open science, informed consent and participatory research in biobanking Y Joly, G Dalpé, D So, S Birko PloS one 10 (7), e0129893, 2015 | 59 | 2015 |
| Disease resistance and the definition of genetic enhancement D So, E Kleiderman, SB Touré, Y Joly Frontiers in Genetics 8, 261075, 2017 | 26 | 2017 |
| Epigenetics ELSI: darker than you think? Y Joly, D So, K Saulnier, SOM Dyke Trends in Genetics 32 (10), 591-592, 2016 | 16 | 2016 |
| Commercial opportunities and ethical pitfalls in personalized medicine: a myriad of reasons to revisit the myriad genetics saga D So, Y Joly Current Pharmacogenomics and Personalized Medicine (Formerly Current …, 2013 | 14 | 2013 |
| Clinical trial transparency and orphan drug development: Recent trends in data sharing by the pharmaceutical industry D So, Y Joly, BM Knoppers Public health genomics 16 (6), 322-335, 2014 | 11 | 2014 |
| Open science precision medicine in Canada: points to consider P Granados Moreno, SE Ali-Khan, B Capps, T Caulfield, D Chalaud, ... Facets 4 (1), 1-19, 2019 | 10 | 2019 |
| Analysis of five years of controlled access and data sharing compliance at the International Cancer Genome Consortium Nature Genetics 48 (3), 224-225, 2016 | 10 | 2016 |
| Ethics approval in applications for open-access clinical trial data: an analysis of researcher statements to clinicalstudydatarequest. com D So, BM Knoppers PloS one 12 (9), e0184491, 2017 | 9 | 2017 |
| Assessing public opinions on the likelihood and permissibility of gene editing through construal level theory D So, R Sladek, Y Joly New Genetics and Society 40 (4), 473-497, 2021 | 8 | 2021 |
| The Use and Misuse of Brave New World in the CRISPR Debate D So The CRISPR Journal 2 (5), 316-323, 2019 | 5 | 2019 |
| Science fiction authors’ perspectives on human genetic engineering D So, K Crocker, R Sladek, Y Joly Medical Humanities 48 (3), 285-297, 2022 | 3 | 2022 |
| From goodness to good looks: Changing images of human germline genetic modification D So Bioethics 36 (5), 556-568, 2022 | 3 | 2022 |
| A decision tool to guide the ethics review of a challenging breed of emerging genomic projects Y Joly, D So, G Osien, L Crimi, M Bobrow, D Chalmers, SE Wallace, ... European Journal of Human Genetics 24 (8), 1099-1103, 2016 | 2 | 2016 |
| Genetic disorder as metaphor and the construction of the abnormal self D So McGill University (Canada), 2014 | 1 | 2014 |
| Teaching to the test KM Saulnier, D So, Y Joly Journal of Law and the Biosciences 3 (2), 373-376, 2016 | | 2016 |
Katie SaulnierCentre of Genomics and PolicyVerified email at mcgill.ca
